MedPath

Chronotype Profiling in Patients with Non-Alcoholic Fatty Liver Disease

Recruiting
Conditions
Steatotic liver disease (SLD) [K76.0, K75.8]
K76.0
K75.8
Fatty (change of) liver, not elsewhere classified
Other specified inflammatory liver diseases
Registration Number
DRKS00033642
Lead Sponsor
niversitätsklinikum Knappschaftskrankenhaus Bochum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

NAFLD patients:
1. diagnosed non-alcoholic fatty liver disease (NAFLD).
2. declaration of consent to participate in the study and privacy policy.
Liver-healthy controls:
1. exclusion of non-alcoholic fatty liver disease (NAFLD).
2. age / gender / body mass index matched to an already recruited patient.
Age match included ±2 years.
3. declaration of consent to participate in the study and privacy policy.

Exclusion Criteria

Controls and NAFLD patients:
1. age under 18 years.
2. taking medication or other current therapies that may affect sleep. sleep may be affected.
3. presence of other chronic liver disease (viral hepatitis, autoimmune hepatitis, alcoholic liver disease, cholangitis, drug-associated liver damage, etc.).
4. presence of a tumor disease.
5. moderate to severe psychopathological disorders
6. eye diseases or other conditions that do not permit light dosimetry.
7. lack of prerequisites for the performance of actigraphy (e.g. physical illnesses that are associated with a significant restriction of physical activity)
8. lack of prerequisites for keeping the required diaries.
9. pregnancy or breastfeeding.
10. traveling across time zones during the outpatient study phase.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Establish comprehensive multiparametric circadian rhythms for patients with NAFLD and healthy controls.
Secondary Outcome Measures
NameTimeMethod
Identification of differences between healthy controls and patients with NAFLD in terms of frequency and extent of disruption of circadian rhythms (chronodisruption).
© Copyright 2025. All Rights Reserved by MedPath